Investigational agents for the treatment of asthma

被引:1
|
作者
Wenzel, SE [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Natl Jewish Med & Res Ctr, Denver, CO 80206 USA
关键词
D O I
10.1016/S0091-6749(98)70235-0
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:S421 / S423
页数:3
相关论文
共 50 条
  • [1] Investigational pharmacological agents for the treatment of ARDS
    Aribindi, Katyayini
    Lim, Michelle
    Lakshminrusimha, Satyan
    Albertson, Timothy
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024, 33 (03) : 243 - 277
  • [2] Novel investigational agents for the treatment of scleroderma
    McMahan, Zsuzsanna Hortobagyi
    Wigley, Fredrick M.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (02) : 183 - 198
  • [3] INVESTIGATIONAL DRUG SHOWS PROMISE IN TREATMENT OF ASTHMA
    TOWNLEY, RG
    AMERICAN FAMILY PHYSICIAN, 1995, 52 (02) : 603 - 603
  • [4] Investigational Agents for the Treatment of Resistant Yeasts and Molds
    Garret T. Seiler
    Luis Ostrosky-Zeichner
    Current Fungal Infection Reports, 2021, 15 : 104 - 115
  • [5] Investigational Agents for the Treatment of Resistant Yeasts and Molds
    Seiler, Garret T.
    Ostrosky-Zeichner, Luis
    CURRENT FUNGAL INFECTION REPORTS, 2021, 15 (03) : 104 - 115
  • [6] Investigational agents in development for the treatment of ovarian cancer
    Westin, Shannon N.
    Herzog, Thomas J.
    Coleman, Robert L.
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (01) : 213 - 229
  • [7] Investigational agents for treatment of traumatic brain injury
    Xiong, Ye
    Zhang, Yanlu
    Mahmood, Asim
    Chopp, Michael
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (06) : 743 - 760
  • [8] Investigational agents in development for the treatment of ovarian cancer
    Shannon N. Westin
    Thomas J. Herzog
    Robert L. Coleman
    Investigational New Drugs, 2013, 31 : 213 - 229
  • [9] New investigational agents for the treatment of major depressive disorder
    Pochwat, Bartlomiej
    Krupa, Anna Julia
    Siwek, Marcin
    Szewczyk, Bernadeta
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (10) : 1053 - 1066
  • [10] Early investigational agents for the treatment of benign prostatic hyperplasia'
    Katsimperis, Stamatios
    Kapriniotis, Konstantinos
    Manolitsis, Ioannis
    Bellos, Themistoklis
    Angelopoulos, Panagiotis
    Juliebo-Jones, Patrick
    Somani, Bhaskar
    Skolarikos, Andreas
    Tzelves, Lazaros
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024, 33 (04) : 359 - 370